Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cellular & molecular immunology 2020-07, Vol.17 (7), p.765-767
Hauptverfasser:	Xia, Shuai, Zhu, Yun, Liu, Meiqin, Lan, Qiaoshuai, Xu, Wei, Wu, Yanling, Ying, Tianlei, Liu, Shuwen, Shi, Zhengli, Jiang, Shibo, Lu, Lu
Format:	Artikel
Sprache:	eng
Schlagworte:	631/154/555 631/80/304 Amino Acid Sequence Antibodies Betacoronavirus - drug effects Betacoronavirus - physiology Biomedical and Life Sciences Biomedicine Conserved Sequence Coronavirus Infections - drug therapy Coronavirus Infections - virology Correspondence COVID-19 Humans Immunology Medical Microbiology Microbiology Models, Molecular Pandemics Pneumonia, Viral - drug therapy Pneumonia, Viral - virology Protein Interaction Domains and Motifs SARS Virus - physiology SARS-CoV-2 Species Specificity Spike Glycoprotein, Coronavirus - antagonists & inhibitors Spike Glycoprotein, Coronavirus - chemistry Spike Glycoprotein, Coronavirus - physiology Spike protein Vaccine Viral Fusion Protein Inhibitors - pharmacology Virus Internalization - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!